刚刚,杀出个医药大白马,超越恒瑞医药!

飞鲸投研
09 Jul

一波未平,一波又起。最近,科伦药业正值多事之秋。2025年7月,公司有两种药品的相关批号依申请被注销。而在此之前,科伦药业的业绩才刚“翻车”不久。2025年一季度,公司营收和净利润双降,营收同比下滑29.42%到43.9亿元;净利润同比下滑43.07%到5.84亿元,与其往年业绩形成强烈反差。要知道,2020-2024年公司业绩都在稳步上升,营收从164.6亿元持续增长到218.1亿元;净利润更是...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10